Patent ID: 7238656
Filing Date: 2007-07-03
Classification: A61K

Abstract:
1. A pharmaceutical composition comprising as an active ingredient a peptide selected from the group consisting of: H-Lys-Gly-Asn-Tyr-Ala-Glu-Arg-Ileu-Ala-OH (SEQ ID NO: 1); H-Asp-Thr-Glu-Phe-Glu-Ala-Ala-Gly-Gly-Gly-Val-Arg-OH (SEQ ID NO:2); H-Thr-Thr-Asp-Thr-Glu-Phe-Glu-Ala-Ala-Gly-Gly-Gly-Val-Arg-OH (SEQ ID NO:4); H-Lys-Gly-Asn-Tyr-MeAla-Glu-Arg-Ileu-Ala-OH (SEQ ID NO: 5); H-Lys-Gly-Asn-Tyr-Ala-Glu-Arg-MeIleu-Ala-OH (SEQ ID NO:6); H-Lys-MeGly-Asn-Tyr-Ala-Glu-Arg-Ileu-Ala-OH (SEQ ID NO:7); H-Lys-MeGIy-Asn-Tyr-Ala-Glu-Arg-MeIleu-Ala-OH (SEQ ID NO:8); H-Lys-Gly-His-Tyr-Ala-Glu-Arg-Val-Gly-OH (SEQ ID NO: 13); H-Lys-Gly-Asn-Tyr-Ala-Glu-Arg-Val-Gly-OH (SEQ ID NO: 10); H-Lys-Ala-His-Tyr-Ser-Glu-Arg-Val-Gly-OH (SEQ ID NO: 12); H-Lys-Ser-Arg-Thr-Thr-Ser-His-Gly-Arg-Val-Gly-OH (SEQ ID NO: 14) H-Lys-Gly-Asn-Tyr-Ser-Glu-Arg-Val-Gly-OH (SEQ ID NO:11) H-Lys-MeGly-Asn-Tyr-MeAla-Glu-Arg-MeIleu-Ala-OH (SEQ ID NO:16); and their N-methylated analogs, together with a pharmaceutically acceptable diluent or excipient.